ロード中...
Alzheimer's disease drug development pipeline: 2017
INTRODUCTION: There is an urgent need to develop new treatments for Alzheimer's disease (AD) and to understand the drug development process for new AD therapies. METHODS: We assessed the agents in the AD pipeline as documented in clinicaltrials.gov for phase I, phase II, and phase III, accessed...
保存先:
| 出版年: | Alzheimers Dement (N Y) |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5651419/ https://ncbi.nlm.nih.gov/pubmed/29067343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2017.05.002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|